NASDAQ · TNDM
Tandem Diabetes Care, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for TNDM: Nov 05, 2026
Tandem Diabetes Care, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 7 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.27. The reported EPS for the same quarter last year was $-0.31.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.27 | $-0.22 | $-0.36 | 7 |
| Dec 2026 | $0.17 | $0.29 | $0.05 | 6 |
| Mar 2027 | $-0.15 | $-0.06 | $-0.19 | 5 |
| Jun 2027 | $-0.09 | $-0.05 | $-0.17 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · MarketBeat · The Motley Fool- Zacks · Oct 29, 9:00 AM EDTTandem Diabetes Care, Inc. (TNDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseTandem Diabetes Care (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 9, 9:05 AM EDTIs it the Right Time to Hold TNDM Stock in Your Portfolio?Tandem Diabetes is advancing next-generation insulin delivery technology and international expansion, but competition and supply constraints pose challenges to growth.
- Fintel · Oct 7, 1:12 PM EDTBarclays Initiates Coverage of Tandem Diabetes Care at Equal-WeightFintel reports that on October 7, 2026, Barclays initiated coverage of Tandem Diabetes Care (NASDAQGM:TNDM) (LSE:0M0F) with a Equal-Weight recommendation.Tandem Diabetes Care, Inc., based in the United States, operates in the healthcare sector and designs, develops, and commercia
- Zacks · Sep 17, 5:34 AM EDTTandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
- Zacks · Sep 9, 2:38 PM EDTReasons to Retain Tandem Diabetes Stock in Your Portfolio NowTNDM's expanding pump lineup and pay-as-you-go model support growth prospects, though macro and competitive pressures remain.
- Zacks · Aug 31, 11:29 AM EDTAging Population Drives Healthcare Growth: Stocks to WatchAbbVie, Tandem Diabetes Care and Amgen are targeting aging-related healthcare growth through advances in immunology, diabetes and cardiovascular care.
- Zacks · Aug 25, 9:33 AM EDTCan PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?Insulet's Q2 beat and stronger margins contrast with a 2026 growth reset, putting U.S. Type 2 retention at the center of its outlook.
- MarketBeat · Aug 18, 2:02 AM EDTTandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless MobiTandem Diabetes Care (NASDAQ:TNDM) highlighted its plans to expand insulin pump adoption through a shift to pharmacy distribution in the U.S., direct sales in additional international markets and upcoming product launches, including a tubeless version of its Tandem Mobi pump. Sp
- The Motley Fool · Aug 13, 9:17 PM EDTTandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 12, 8:39 AM EDTTNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock UpTandem Diabetes shares jump 19.1% after a narrower-than-expected Q2 loss, as higher pump shipments and a 57% gross margin offset a slight revenue miss.
- MarketBeat · Aug 7, 2:04 PM EDTTandem Diabetes Care Q2 Earnings Call HighlightsTandem Diabetes Care (NASDAQ:TNDM) reported second-quarter results that included record sales, pump shipments and gross margin for a second quarter, while management highlighted early progress in its transition to pharmacy-channel reimbursement and continued development of new in
- Zacks · Aug 6, 7:10 PM EDTTandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue EstimatesTandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +8.82% and -0.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Tandem Diabetes Care, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.